Supply Chain

Medtronic on Tuesday released financial results for the third quarter of fiscal year 2017.

Data from CMS projections and pharmacy benefit manager reports show a decline in drug spending growth.

Cleveland Clinic President and CEO Toby Cosgrove, MD, cited high drug costs as part of the reason the health system's operating income fell in fiscal year 2016, reports Cleveland.com.

Intermountain Health Care in Salt Lake City is widely known as a leader in supply chain — it was among the first round of health systems to implement its own self-distribution network a decade ago, and Gartner named it the…

Charlotte, N.C.-based group purchasing organization Premier on Monday launched a new automated data analytics solution for healthcare providers.

President Donald Trump's call to deregulate the Food and Drug Administration has drawn much attention to the agency's drug approval process, reports Business Insider.

President Donald Trump's proposal to let CMS negotiate drug prices could limit seniors' access to beneficial treatments, Rafael Fonseca, MD, a hematologist and oncologist at the Mayo Clinic in Phoenix, said in an op-ed for The Hill.

While the Food and Drug Administration requires devicemakers to conduct postmarket surveillance to monitor the safety of their products, they often wait too long before recalling devices, according to a study published in Production and Operations Management.

While Marathon Pharmaceuticals' $89,000 price tag for its Duchenne muscular dystrophy drug Emflaza garnered much criticism last week, Marathon CEO Jeff Aronin insists the treatment will be affordable for patients, reports Chicago Tribune.

Here are four drugs and medical devices approved by the Food and Drug Administration this past week.